M4MM

Filament Health Reports Q2 2024 Results

LOS ANGELES- Filament Health Corp, a clinical psychedelic drug development company, has released its financial results for the second quarter ending June 30, 2024. The company highlighted its progress in advancing drug candidates targeting substance ...

Week In Review: Canopy Growth to Fully Acquire Acreage Holdings in Strategic Expansion: California Reinvests Cannabis Tax Revenue to Support Communities: Vermont Medical Cannabis Patient Appeals Denial of Unemployment Benefits to State Supreme Court:

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...

Filament Health Reports Q2 2024 Results

LOS ANGELES- Filament Health Corp, a clinical psychedelic drug development company, has released its financial results for the second quarter ending June 30, 2024. The company highlighted its progress in advancing drug candidates targeting substance ...

BLAZE Raises $8 Million in Series A Funding

LOS ANGELES – BLAZE, a growing, enterprise resource planning and point of sale platform for legal cannabis, recently closed its Series A funding round at $8 million. The round was led by Delta Emerald Ventures ...

Sweet Flower Announces Close of $15 million Series A investment

LOS ANGELES–Investment gives Sweet Flower funding to rapidly expand across California, launch manufacturing and distribution verticals and new retail brand. Sweet Flower, Southern California's leading cannabis retailer announced today that the Company has successfully raised ...

Horizons ETFs Rebalances Cannabis-Focused Index ETFs

TORONTO–Horizons ETFs Management (Canada) Inc. has completed the quarterly rebalances of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and the Horizons US Marijuana Index ETF (NEO: HMUS). HMMJ is ...

Subscribe To Our Newsletter